Vascular Solutions' thrombus extractor:
This article was originally published in Clinica
Executive Summary
Vascular Solutions has received US FDA 510(k) clearance to sell a version of its Pronto extraction catheter that is sufficiently large but also short enough to remove thrombus from haemodialysis grafts and fistulas. The Pronto-Short device will be used to treat the relatively large-sized grafts and fistulas, which are prone to clotting, with patients requiring on average one de-clot procedure each year, according to the Minneapolis, Minnesota firm. The original Pronto device is designed to remove thrombi from arteries. The firm estimates the additional US market opportunity addressed by the Pronto-Short to be around $100m annually.